Apr 23, 2014 ... Gilead (GILD) posted blockbuster sales for Sovaldi, outpacing ... Earnings
Roundup: What You Need to Know About Gilead's Blockbuster Quarter ... Olysio's
sales totaled $350 million in the first quarter as the drug was ...
Apr 26, 2016 ... Gilead Sciences (GILD), which is set to report first-quarter 2016 results on ...
Gilead's blockbuster hepatitis C virus (HCV) drug Harvoni should continue to ...
Here are a couple of other health care stocks that you may want to ... Biotech
Stock Roundup: Amgen's Kyprolis Disappoints, Array Up on Cancer Data.
Jun 8, 2016 ... Late Tuesday, Gilead Sciences (GILD) won a court ruling in its battle with Merck
... property rights behind its blockbuster hepatitis-C drugs Harvoni and Sovaldi. ...
News and commentary about the stocks you need to know about today ... 2016
but generated only $50 million of sales in the first quarter of 2016.
Mar 2, 2016 ... The fourth quarter earnings season is winding down, with quite a few ... The
sooner you can start, the better ... Biotech Stock Roundup: Gilead HIV Drug
Approved, Baxalta in ... HIV treatments to market and to boost sales of its
blockbuster HIV ... T cell therapies targeting areas of major unmet need in cancer.
May 4, 2016 ... Big names in the biotech sector reported earnings over the last five trading ...
Vertex's first quarter results were also disappointing with the ... According to
AbbVie, the candidate has blockbuster potential and ... The company plans to
speed up its efforts to bring new treatments .... Know how many I've done?
Sep 14, 2016 ... Beyond this Analyst Blog, would you like to see Zacks' best .... Apple Car rumor
roundup: Here's everything you need to know about 'Project Titan' .... its third-
quarter earnings, which it expects to announce late next month. ... In the near
term, Gilead investors should take a more bullish view of the s...
Jun 30, 2016 ... Biotech Stock Roundup ... Meanwhile, Gilead continues to expand its blockbuster
HCV franchise. ... and will focus on submitting a NDA in the fourth quarter of 2016
. .... Yahoo Confirms Massive Data Breach: What You Need to Know ..... be a
better indicator of your future employability and earnings potential.
Income, -57.20M, PEG, -, EPS next Q, -0.64, Inst Own, 70.50%, Short Float, 2.53
% ... Sep-22-16 04:35PM, Gilead, Allergan Seen Trailing Intercept In Ongoing ...
08:39AM, Biotech Stock Roundup: Tobira Soars on Acquisition Deal, FDA ... 04:
00PM, STOCKS DO NOTHING AHEAD OF THE FED: Here's what you need to
May 24, 2016 ... But a mix of accounting and politics could cause one or both to need another
taxpayer .... that the continuing labor strike may impact its second-quarter results.
... Intuit Reports Better-Than-Expected Earnings ... Gilead Names New Operating
Chief Gilead Sciences Inc. on ..... Here is what you need to know.
Blockbuster biotech deal coming? ... The cost of naloxone has spiraled upwards,
even as the drug has become more desperately needed to reverse overdoses.